Hospital "super super bug" stronger than MRSA

According to reports eleven patients at a British hospital have acquired a superbug said to be stronger than MRSA.

The bug known as gentamicin resistant MRSA, does not react to standard drugs used to treat the bacteria and apparently causes blood poisoning and chest infections.

Walsgrave hospital in Coventry says it is not aware of any deaths associated with the strain which was first identified during routine screening in June.

A hospital microbiologist has said the strain is particularly recognisable because of its very resistant sensitivity pattern.

The super strain has apparently occurred in two intensive care units, and in a high dependency unit.

Five incidents have occurred in just 10 days between August and September, while eight were likely to have been acquired in the hospital.

As well as gentamicin, a frontline antibiotic in the treatment of MRSA, the strain is also resistant to mupirocin, fucidin, rifampicin.

The medical director for the hospital Martin Lee, says the hospital is one of the 10 most improved centres in fighting hospital acquired infections.

He says one patient in intensive care was identified as having the resistant strain of MRSA during routine screening, and when further tests were carried out, nine other patients were also found with it on their skin.

Lee says that since then there has only been one other isolated case and no higher rate of complication has been identified of gentamicin resistant MRSA.

Also no other patients were identified as having this form of MRSA on wards where these patients were transferred to.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Children's Colorado earns prestigious cardiomyopathy recognition